Your username will only be remembered on this device. For your security, only the first and last digits will be shown. Only the most recently "remembered" username will be saved.
Also known as User ID
Enter your ZIP code to learn about the CarePlus Medicare Advantage plans in your area, or call us at 1-855-605-6171; TTY: 711.
Read about pharmacy-related safety alerts, announcements and other medication-related information.
PDFDrug recall notice for all ranitidine products (PDF opens in new window)
PDFDrug recall notice for Taro Pharmaceuticals phenytoin oral suspension (PDF opens in new window)
PDFDrug recall notice for Belviq, Belviq XR (lorcaserin) (PDF opens in new window)
PDFFAQ and information about the launch of generic Symbicort HFA inhaler (PDF opens in new window)
PDFInformation about the launch of generic Afinitor (PDF opens in new window)
PDFInformation about the launch of deferasirox (generic of Jadenu) (PDF opens in new window)
PDFDrug recall notice for Natpara (PDF opens in new window)
PDFImpact of ongoing angiotensin II receptor blocker (ARB) drug recalls (PDF opens in new window)
PDFChanges to CarePlus 2020 Formularies (PDF opens in new window)
Access prescription drug guides and Part D utilization management requirements by visiting the CarePlus Prescription Drug Information page.
Find out how to request a coverage determination for a Part D prescription drug and access coverage determination request forms.
PDFHow to Request a Coverage Determination or an Exception (PDF opens in new window)
PDFPrescription Drug Coverage Determination Request Form (PDF opens in new window)
If you prefer, you may complete the Coverage Determination Request (link opens in new window) . Before completing the online request, you may want to view our accepted file types (link opens in new window) .
You also can access the Medicare Coverage Determination Request Form at the following CMS Part D webpage link: Part D Coverage Determination Request Form (link opens in new window) .
To learn how we help eligible members better understand their medications, please visit our MTM Program page.
In August of 2018, the Centers for Medicare & Medicaid Services (CMS) rescinded its September 2012 memo “Prohibition on Imposing Mandatory Step Therapy for Access to Part B Drugs and Services,” and now allows Medicare Advantage (MA) plans to apply step therapy for physician-administered and other Part B drugs.
Step therapy is a type of prior authorization for drugs that require patients to initiate treatment for a medical condition with the most preferred drug therapy. Patients then progress to other therapies only if necessary.
Due to this recent change, CarePlus will require a review of some injectable drugs and biologics for step therapy requirements in addition to current review requirements. The affected drugs/devices are indicated on the PDFPart B Step Therapy Preferred Drug List (PDF opens in new window) .
CarePlus makes arrangements to continue to provide necessary drugs to our members through a transition period. Read about our Part D transition policy.
PDFPart D Prescription Drug Plan Transition Policy for Providers (PDF opens in new window)
CarePlus appreciates your participation and role in delivering quality pharmacy services to your CarePlus-covered patients. The CarePlus Pharmacy Manual is intended to assist pharmacy staff in processing claims for CarePlus plans.
